New Florida Law Allows Telemedicine Prescribing of Controlled Substances

07 April 2022 Health Care Law Today Blog
Author(s): Nathaniel M. Lacktman

Florida has taken another step towards expanding telemedicine.  On April 6, 2022, Governor Ron DeSantis signed into law legislation to remove Florida’s prior restrictions on telemedicine prescribing of controlled substances. Previously, Florida had a general prohibition on prescribing controlled substances via telemedicine, with only narrow exceptions. The new law (SB 312) eliminates the ban for all controlled substances except Schedule II. Schedule II drugs can be prescribed via telemedicine, but only if the clinical situation meets one of the four narrow exceptions (more on that below). 

The law is a big win for Florida patients with medical conditions requiring controlled substances as part of the treatment regimen. This includes, for example, endocrinology or substance use disorder (both of which use Schedule III medications now permitted under the new law), allowing these patients to obtain better access to more fulsome care. The law will also allow Florida clinicians to more easily prescribe refills in connection with their ongoing care management because the clinician can periodically conduct patient exams via telemedicine instead of requiring in-person exams even when those exams might be viewed as medically unnecessary. 

Some stimulant medications commonly prescribed in psychiatry are Schedule II drugs, which could potentially meet one of the pre-existing exceptions if they are prescribed for treatment of a psychiatric disorder.  Most opioids are Schedule II drugs not allowed under this new law.

Florida as a National Leader in Telemedicine Policy

Well before the COVID Public Health Emergency, Florida policymakers had the foresight to favorably position the Sunshine State with some of the most forward-thinking telemedicine laws in the United States.  This vision was reflected in the Board of Medicine granting waivers to telemedicine providers under pilot programs dating back to 2014 (e.g., telepsychiatry, asynchronous prescribing, obesity). The Legislature then created a groundbreaking State-sponsored Telehealth Advisory Council in 2016.  That same year, the Board of Medicine allowed telemedicine prescribing of controlled substances for treatment of psychiatric disorders. In 2019, lawmakers enacted a complete overhaul of Florida telehealth laws and created a registration process to allow out-of-state clinicians to quickly and easily obtain permission to treat Florida patients via telemedicine. And there is a rulemaking workshop currently rewriting certain regulations to better accommodate telemedicine models. (Read Foley’s comments on that rule here.)

The result of this multi-year effort allowed Florida residents to enjoy increased access to medical care, including behavioral health, while still giving the Department of Health regulatory oversight on quality. When the COVID Public Health Emergency occurred, Florida implemented additional waivers allowing even more broad use of telemedicine, eventually sunsetting them last year. (Our prior discussions of Florida’s telehealth waivers are available herehere, and here.)

What is Florida’s Controlled Substance Telemedicine Prescribing Law?

The new law amends Florida’s telehealth statute as follows (new text is underlined):

Florida Statutes 456.47 Use of telehealth to provide services.



(c) A telehealth provider may not use telehealth to prescribe a controlled substance listed in Schedule II of s. 893.03 unless the controlled substance is prescribed for the following:
1. The treatment of a psychiatric disorder;
2. Inpatient treatment at a hospital licensed under chapter 20 395;
3. The treatment of a patient receiving hospice services as defined in s. 400.601; or
4. The treatment of a resident of a nursing home facility as defined in s. 400.021.

The law is effective starting July 1, 2022.

What About Federal Laws?

Clinicians should continue to be mindful of prescribing requirements under federal laws, as telemedicine prescribing of controlled substances is also governed by the Ryan Haight Act.  Among other things, the Ryan Haight Act requires a threshold in-person examination between the prescriber and the patient, although there are seven exceptions for the practice of telemedicine

Florida law must be read in harmony with the Ryan Haight Act requirements, and a prescriber must comply with both Florida and federal laws in this regard. Clinicians delivering care via telemedicine, particularly across multiple states, must understand and navigate many intersecting state and federal laws on telemedicine, medical practice, fraud and abuse, and controlled substances.

Want to Learn More?

For more information on telemedicine, telehealth, virtual care, remote patient monitoring, digital health, and other health innovations, including the team, publications, and representative experience, visit Foley’s Telemedicine & Digital Health Industry Team.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.